FDA Import Refusal SCS-3970872-7/10002/1 — Boehringer Ingelheim
The FDA refused shipment SCS-3970872-7/10002/1 from Boehringer Ingelheim (France) on Sep 9, 2025. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charges: 118,3280 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 9, 2025
- Country
- France
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 118,3280